Blockade of the nuclear factor kappa B pathway prolonged islet allograft survival.

Nuclear factor kappa B (NF-κB) pathway is known for its important role in the upregulation of various inflammatory mediators and its "switch regulator" functionality for transcription factor gene networks which control cytokine-induced β-cell dysfunction and death. In this study, the islets were divided into the control group, Ad-green fluorescent protein, and the adenovirus transfected with inhibitor kappa B group. The proliferation index of peripheral blood mononuclear cells and the islets apoptosis index were examined after mixed lymphocyte-islet reaction with inverted fluorescence microscopy. Moreover, mRNA expression of inflammatory cytokines was measured by reverse transcription polymerase chain reaction. The islet graft survival time in diabetic rats, insulin in grafts, and cytokine concentrations in the supernatant were determined by immunohistochemistry and enzyme-linked immunosorbent assay. We found that blocking of NF-κB activation in β-cells significantly downregulated inflammatory chemokine production by islets cells in vitro and in vivo, inhibited T-cell recruitment into the pancreatic islets, inhibited β-cell dysfunction, and effectively prolonged the survival time of islet grafts. The results presented in this work highlight a novel mechanism of blocking NF-κB activation in β-cells for the treatment of islet cell transplantation.

[1]  I. Noronha,et al.  Induction of Indoleamine 2,3‐Dioxygenase by Gene Delivery in Allogeneic Islets Prolongs Allograft Survival , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  J. Farber,et al.  CXC Chemokine Ligand (CXCL) 9 and CXCL10 Are Antagonistic Costimulation Molecules during the Priming of Alloreactive T Cell Effectors , 2010, The Journal of Immunology.

[3]  R. Bottino,et al.  Long‐Term Controlled Normoglycemia in Diabetic Non‐Human Primates After Transplantation with hCD46 Transgenic Porcine Islets , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  E. Chaikof,et al.  Thrombomodulin Improves Early Outcomes After Intraportal Islet Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  M. Kapsenberg,et al.  Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. , 2007, The Journal of investigative dermatology.

[6]  G. Courtois,et al.  Mutations in the NF-κB signaling pathway: implications for human disease , 2006, Oncogene.

[7]  S. Matsumoto,et al.  Evaluation of Islet Transplantation from Non‐Heart Beating Donors , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Yuichiro Yamada,et al.  Insulin independence after living-donor distal pancreatectomy and islet allotransplantation , 2005, The Lancet.

[9]  L. Adorini,et al.  A Vitamin D Analog Down-Regulates Proinflammatory Chemokine Production by Pancreatic Islets Inhibiting T Cell Recruitment and Type 1 Diabetes Development1 , 2004, The Journal of Immunology.

[10]  H. Auchincloss,et al.  Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo1 , 2004, The Journal of Immunology.

[11]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[12]  P. Giangrande,et al.  The interaction between primate blood and mouse islets induces accelerated clotting with islet destruction , 2002, Xenotransplantation.

[13]  M. Kruhøffer,et al.  A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-κB-dependent Genes in Primary Rat Pancreatic β-Cells* , 2001, The Journal of Biological Chemistry.

[14]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[15]  M. Kruhøffer,et al.  Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. , 2001, Diabetes.

[16]  A. Gaber,et al.  Human Pancreatic Islets Transfected to Produce an Inhibitor of TNF are Protected against Destruction by Human Leukocytes , 2000, Cell transplantation.

[17]  F. Pociot,et al.  Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans. , 2000, Diabetes.

[18]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[19]  D. Grunwald,et al.  Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: simultaneous assessment of proliferation, apoptosis, and necrosis. , 2000, Cytometry.

[20]  H. Pahl Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[21]  G. Elgue,et al.  Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? , 1999, Diabetes.

[22]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[23]  G. Cirino,et al.  Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. , 1998, Life sciences.

[24]  P. Sanberg,et al.  Post-thaw viability and functionality of cryopreserved rat fetal brain cells cocultured with Sertoli cells. , 1997, Cell transplantation.

[25]  Y. Yamashita,et al.  Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. , 1994, Biochemical and biophysical research communications.